2016 NCCN Guidelines |
No follow-up needed |
CT at 3 mo, and annual CT for at least 3 years |
CT at 3 mo, and annual CT for at least 3 years |
|
CT at 3 mo, and annual CT for at least 3 years |
Biopsy or surgical resection |
Biopsy or surgical resection |
Biopsy or surgical resection |
2017 Fleischner Society Guidelines |
No follow-up needed |
No follow-up needed |
CT at 6-12 mo to confirm persistence, then CT every 2 years until 5 years |
|
No follow-up needed |
No follow-up needed |
CT at 3-6 mo to confirm persistence, if unchanged and solid component remains 6 mm, annual CT should be performed for 5 years |
CT at 3-6 mo to confirm persistence, if unchanged and solid component remains 6 mm, annual CT should be performed for 5 years |
2013 ACCP Guidelines |
No follow-up needed |
Annual CT for at least 3 years |
Annual CT for at least 3 years |
|
CT at 3, 12, 24 mo, and then annual CT for at 1-3 years |
CT at 3, 12, 24 mo, and then annual CT for at 1-3 years |
CT at 3, 12, 24 mo, and then annual CT for at 1-3 years |
CT at 3 mo to confirm, persistencIf persistent, biopsy surgical resection if a nodule >15 mm at first CT scan,then biopsy, PET or surgical resection |
2016 Clinical practice consensus guidelines for Asia |
Discuss role of continued surveillance with patient |
Annual CT surveillance for at least 3 years, consider ongoing annual CT surveillance after discussion with patient |
Annual CT surveillance for at least 3 years, consider ongoing annual CT surveillance after discussion with patient |
|
CT at 3, 12, 24 mo, and then annual CT surveillance |
CT at 3, 12, 24 mo, and then annual CT surveillance |
CT at 3, 12, 24 mo, and then annual CT surveillance |
CT at 3 mo, and consider antimicrobial therapy (nonsurgical or surgical biopsy consider PET scanning for staging before biopsy) |